⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3032328 | 0.83 | — | — | |
| SCHEMBL15766660 | 0.83 | — | — | |
| SCHEMBL5880658 | 0.81 | — | — | |
| SCHEMBL366803 | 0.79 | MAPT (0.43) | — | |
| SCHEMBL8443918 | 0.77 | MAPT (0.46) | — | |
| SCHEMBL15092903 | 0.77 | MAPT (0.46) | — | |
| SCHEMBL11044745 | 0.77 | MAPT (0.46) | — | |
| SCHEMBL514687 | 0.73 | — | — | |
| SCHEMBL650952 | 0.72 | — | — | |
| SCHEMBL271616 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0137832-B1 | PHARMACEUTICAL COMPOSITIONS OF ANTI-PANCREATIC INFLAMMATORY EFFECT | BIOGAL GYOGYSZERGYAR (HU) | 1987-08-12 | — | — | EP | claimed |
| EP-2451955-B1 | PROCESS FOR PREPARATION OF TACROLIMUS | LEK PHARMACEUTICALS (SI) | 2018-01-24 | — | — | EP | disclosed |
| US-9505779-B2 | Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same | INTRON BIOTECHNOLOGY, INC. (KR) | 2016-11-29 | — | — | US | disclosed |
| US-20130230559-A1 | NOVEL TACROLIMUS ANALOGUES, A NEUROPROTECTIVE COMPOSITION COMPRISING THE SAME, AN IMMUNOSUPPRESSIVE COMPOSITION COMPRISING THE SAME, A METHOD FOR PREPARING THE SAME, AND A MUTANT FOR PRODUCING THE SAME | Ewha University - Industry Collaboration Foundatio (KR) | 2013-09-05 | — | — | US | disclosed |
| EP-2451955-A1 | PROCESS FOR PREPARATION OF TACROLIMUS | LEK Pharmaceuticals d.d. (SI) | 2012-05-16 | — | — | EP | disclosed |
| WO-2012026665-A1 | NOVEL TACROLIMUS DERIVATIVES, A NEUROPROTECTIVE COMPOSITION COMPRISING THE SAME, AN IMMUNOSUPPRESSIVE COMPOSITION COMPRISING THE SAME, A METHOD FOR PREPARING THE SAME, AND A MUTANT FOR PRODUCING THE SAME | EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION (KR) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011004008-A1 | PROCESS FOR PREPARATION OF TACROLIMUS | LEK PHARMACEUTICALS D.D. (SI) | 2011-01-13 | — | — | WO | disclosed |
| EP-2272963-A1 | Process for Preparation of Tacrolimus | LEK Pharmaceuticals d.d. (SI) | 2011-01-12 | — | — | EP | disclosed |
| EP-1793846-A4 | COMPOSITIONS AND METHODS COMPRISING VITAMIN B12 AND AN IMPDH INHIBITOR FOR TREATING VIRAL, INFLAMMATORY AND PROLIFERATIVE DISEASES | TRANSITION THERAPEUTICS INC (CA) | 2008-03-26 | — | — | EP | disclosed |
| EP-1793846-A1 | COMPOSITIONS AND METHODS COMPRISING VITAMIN B12 AND AN IMPDH INHIBITOR FOR TREATING VIRAL, INFLAMMATORY AND PROLIFERATIVE DISEASES | Transition Therapeutics Inc. (CA) | 2007-06-13 | — | — | EP | disclosed |
| WO-2006010256-A1 | COMPOSITIONS AND METHODS COMPRISING VITAMIN B12 AND AN IMPDH INHIBITOR FOR TREATING VIRAL, INFLAMMATORY AND PROLIFERATIVE DISEASES | TRANSITION THERAPEUTICS INC. (CA) | 2006-02-02 | — | — | WO | disclosed |
| US-6491981-B1 | PERFLUORINATED POLYORGANOSILOXANES; LOW SURFACE ENERGY AND IMPROVED ADHERENCE; SOIL RELEASE COATINGS FOR TEXTILES; BIS-PERFLUOROMALONATE GRAFTED GROUPS | RHODIA CHIMIE (FR) | 2002-12-10 | — | — | US | disclosed |
| EP-0733364-A1 | MEDICINAL COMPOSITION FOR CIRCULATORY ORGAN | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1996-09-25 | — | — | EP | disclosed |